The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma (original) (raw)

In vivo imaging of glucose consumption and lactate concentration in human gliomas

Annals of Neurology, 1992

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

Cancer Cell International

Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant

Thomas Lewellen

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998

View PDFchevron_right

Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme

Robert Nickles

Journal of Neuro-Oncology, 1993

View PDFchevron_right

Hyperpolarized 13 C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma

Ilwoo Park, Tomoko Ozawa, Myriam Chaumeil

View PDFchevron_right

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

Enikő Vetlényi

Pathology & Oncology Research

View PDFchevron_right

In vitro and in vivo comparison of the MRI glucoCEST properties between native glucose and 3OMG in a murine tumor model

Dario Longo

bioRxiv, 2021

View PDFchevron_right

Quantification of Glucose Utilization in an Experimental Brain Tumor Model by the Deoxyglucose Method

Amami Kato

Journal of Cerebral Blood Flow & Metabolism, 1985

View PDFchevron_right

Multinuclear NMR and MRI reveal an early metabolic response to mTOR inhibition in sarcoma

Kelly McBride Folkers

Cancer research, 2017

View PDFchevron_right

Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor

Naoya Hattori

European journal of nuclear medicine and molecular imaging, 2017

View PDFchevron_right

Effect of acute hyperglycemia on moderately hypothermic GL261 mouse glioma monitored by T1-weighted DCE MRI

Ana Paula Candiota

Magma (New York, N.Y.), 2014

View PDFchevron_right

In vivo imaging of glucose uptake and metabolism in tumors

Marilena Rega

Nature Medicine, 2013

View PDFchevron_right

Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin

Nallathamby Devasahayam

PLoS ONE, 2012

View PDFchevron_right

Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy

Andrea Pirzkall

International Journal of Radiation Oncology*Biology*Physics, 2002

View PDFchevron_right

Metabolism of [U-13C]glucose in human brain tumorsin vivo

Bruce Mickey

NMR in Biomedicine, 2012

View PDFchevron_right

Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy

Michael Garwood, Wanda High

Cancer research, 1998

View PDFchevron_right

Metabolic and molecular imaging in neuro-oncology

David Coop

Lancet Neurology, 2007

View PDFchevron_right

Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models

Mark Muzi

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997

View PDFchevron_right

Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas

Masatsune Ishikawa

Neurologia medico-chirurgica, 1990

View PDFchevron_right

Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-Methyl-D-glucose

Gil Navon

Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine, 2014

View PDFchevron_right

Molecular imaging of tumors by chemical exchange saturation transfer MRI of glucose analogs

Michal Rivlin

Quantitative Imaging in Medicine and Surgery, 2019

View PDFchevron_right

Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience

Sanjeev Chawla, PhD. DABMP

View PDFchevron_right

Brain tumours and their metabolic profiles by magnetic resonance spectroscopy

Regunath Kandasamy

Malaysian Journal of Medicine and Health Sciences, 2020

View PDFchevron_right

Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen

Michael Schroeter

Journal of Neuro-Oncology, 2009

View PDFchevron_right

Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized 13 C‐MRI

Tatsuya Kawai

NMR in Biomedicine, 2021

View PDFchevron_right

Regional glucose utilization and blood flow in experimental brain tumors studied by double tracer autoradiography

Amami Kato, Mirko Diksic

Journal of Neuro-Oncology, 1985

View PDFchevron_right

Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death

Marina Burger

Brain

View PDFchevron_right

Editorial: Structural, Metabolic, and Physiologic MR Imaging to Study Glioblastomas

Sanjeev Chawla, PhD. DABMP

Frontiers in Neurology, 2022

View PDFchevron_right

The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma (original) (raw)

Related papers